Published in Biotech Business Week, January 22nd, 2007
This trend article about University of Arizona, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination," have been published. According to recent research published in the International Journal of Cancer, "Tumor derived chaperone-rich cell lysate (CRCL) when isolated from tumor tissues is a potent vaccine that contains at least 4 of the highly immunogenic heat shock proteins...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.